Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder

To date, there are no biomarkers for major depressive disorder (MDD) treatment response in clinical use. Such biomarkers could allow for individualized treatment selection, reducing time spent on ineffective treatments and the burden of MDD. In search of such a biomarker, multisite pretreatment and...

Full description

Saved in:
Bibliographic Details
Published in:Neuropsychopharmacology
Main Authors: Bartlett, Elizabeth A., DeLorenzo, Christine, Sharma, Priya, Yang, Jie, Zhang, Mengru, Petkova, Eva, Weissman, Myrna, McGrath, Patrick J., Fava, Maurizio, Ogden, R. Todd, Kurian, Benji T., Malchow, Ashley, Cooper, Crystal M., Trombello, Joseph M., McInnis, Melvin, Adams, Phillip, Oquendo, Maria A., Pizzagalli, Diego A., Trivedi, Madhukar, Parsey, Ramin V.
Format: Artigo
Language:Inglês
Published: Springer International Publishing 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135779/
https://ncbi.nlm.nih.gov/pubmed/29955151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-018-0122-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items